# | Title | Journal | Year | Citations |
---|
1 | Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016 | Open Forum Infectious Diseases | 2019 | 456 |
2 | Weight Gain After Fecal Microbiota Transplantation | Open Forum Infectious Diseases | 2015 | 336 |
3 | High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019 | Open Forum Infectious Diseases | 2020 | 327 |
4 | Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections | Open Forum Infectious Diseases | 2015 | 315 |
5 | Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs | Open Forum Infectious Diseases | 2016 | 292 |
6 | Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit | Open Forum Infectious Diseases | 2018 | 255 |
7 | Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options | Open Forum Infectious Diseases | 2020 | 255 |
8 | A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis | Open Forum Infectious Diseases | 2018 | 228 |
9 | Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions | Open Forum Infectious Diseases | 2014 | 202 |
10 | C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation | Open Forum Infectious Diseases | 2020 | 194 |
11 | Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States | Open Forum Infectious Diseases | 2020 | 185 |
12 | Acute Phase Reactants in Infections: Evidence-Based Review and a Guide for Clinicians | Open Forum Infectious Diseases | 2015 | 178 |
13 | The Increase in Hospitalizations for Urinary Tract Infections and the Associated Costs in the United States, 1998–2011 | Open Forum Infectious Diseases | 2017 | 176 |
14 | Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection | Open Forum Infectious Diseases | 2018 | 167 |
15 | Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19) | Open Forum Infectious Diseases | 2020 | 160 |
16 | Monkeypox: A Contemporary Review for Healthcare Professionals | Open Forum Infectious Diseases | 2022 | 156 |
17 | Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysis | Open Forum Infectious Diseases | 2018 | 143 |
18 | An “Infodemic”: Leveraging High-Volume Twitter Data to Understand Early Public Sentiment for the Coronavirus Disease 2019 Outbreak | Open Forum Infectious Diseases | 2020 | 141 |
19 | Vaccine Rejection and Hesitancy: A Review and Call to Action | Open Forum Infectious Diseases | 2017 | 139 |
20 | Hope on the Horizon: Novel Fungal Treatments in Development | Open Forum Infectious Diseases | 2020 | 139 |
21 | Normal Body Temperature: A Systematic Review | Open Forum Infectious Diseases | 2019 | 138 |
22 | Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016) | Open Forum Infectious Diseases | 2019 | 136 |
23 | Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008–2014 | Open Forum Infectious Diseases | 2015 | 135 |
24 | Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety | Open Forum Infectious Diseases | 2019 | 133 |
25 | Twenty-Year Trends in Antimicrobial Susceptibilities Among Staphylococcus aureus From the SENTRY Antimicrobial Surveillance Program | Open Forum Infectious Diseases | 2019 | 132 |
26 | Epidemiology and Clinical Features of Invasive Fungal Infection in a US Health Care Network | Open Forum Infectious Diseases | 2018 | 130 |
27 | Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19 | Open Forum Infectious Diseases | 2021 | 130 |
28 | Postacute COVID-19: An Overview and Approach to Classification | Open Forum Infectious Diseases | 2020 | 128 |
29 | Long COVID and Post-infective Fatigue Syndrome: A Review | Open Forum Infectious Diseases | 2021 | 128 |
30 | Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus | Open Forum Infectious Diseases | 2016 | 124 |
31 | Variations in the Occurrence of Resistance Phenotypes and Carbapenemase Genes Among Enterobacteriaceae Isolates in 20 Years of the SENTRY Antimicrobial Surveillance Program | Open Forum Infectious Diseases | 2019 | 124 |
32 | Risk Factors for Herpes Zoster Infection: A Meta-Analysis | Open Forum Infectious Diseases | 2020 | 124 |
33 | Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1 | Open Forum Infectious Diseases | 2015 | 119 |
34 | Prevalence of Carbapenem-Resistant Gram-Negative Infections in the United States Predominated by Acinetobacter baumannii and Pseudomonas aeruginosa | Open Forum Infectious Diseases | 2017 | 113 |
35 | Invasive Aspergillosis Associated With Severe Influenza Infections | Open Forum Infectious Diseases | 2016 | 108 |
36 | Infectious Complications of Multiple Sclerosis Therapies: Implications for Screening, Prophylaxis, and Management | Open Forum Infectious Diseases | 2018 | 107 |
37 | Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature | Open Forum Infectious Diseases | 2017 | 103 |
38 | Serum Iron Level as a Potential Predictor of Coronavirus Disease 2019 Severity and Mortality: A Retrospective Study | Open Forum Infectious Diseases | 2020 | 102 |
39 | Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019 | Open Forum Infectious Diseases | 2020 | 101 |
40 | Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia | Open Forum Infectious Diseases | 2020 | 101 |
41 | Host Characteristics and Bacterial Traits Predict Experimental Virulence for Escherichia coli Bloodstream Isolates From Patients With Urosepsis | Open Forum Infectious Diseases | 2015 | 100 |
42 | Outpatient Parenteral Antimicrobial Therapy Among People Who Inject Drugs: A Review of the Literature | Open Forum Infectious Diseases | 2018 | 100 |
43 | Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era | Open Forum Infectious Diseases | 2021 | 99 |
44 | Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19 | Open Forum Infectious Diseases | 2020 | 97 |
45 | Risk of Tuberculosis Infection and Disease for Health Care Workers: An Updated Meta-Analysis | Open Forum Infectious Diseases | 2017 | 95 |
46 | Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial | Open Forum Infectious Diseases | 2015 | 92 |
47 | Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections | Open Forum Infectious Diseases | 2021 | 92 |
48 | Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study | Open Forum Infectious Diseases | 2021 | 91 |
49 | Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study | Open Forum Infectious Diseases | 2017 | 89 |
50 | Automated Outbreak Detection of Hospital-Associated Infections | Open Forum Infectious Diseases | 2015 | 86 |